Zhittya Genesis Medicine’s Investigational Therapy for Parkinson’s to Enter Phase 1 Trials in Mexico

Zhittya Genesis Medicine’s Investigational Therapy for Parkinson’s to Enter Phase 1 Trials in Mexico
Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) has granted approval for the first in-human clinical trial of Zhittya Genesis Medicine‘s (ZGM)’s investigational therapy for Parkinson’s disease. Parkinson’s is characterized by the death of dopamine-producing neurons in the brain. A hypothesis that has gained traction in recent years asserts this may be, at least in part, a result ... read more
Source: Parkinson’s News TodayPublished on 2020-02-18By Marisa Wexler